Skip to main content

JACOBS LEVY EQUITY MANAGEMENT, INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 884414 FLORHAM PARK, NJ

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$122,378,916
+$53,838,678 QoQ
Shares Held
726,112
+39.6% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#21
of 772 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (39.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
726,112 $122,378,916

All Filings in NBIX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $122,378,916 726,112
2026-03-31 $68,540,238 520,269
2025-12-31 $4,953,554 34,926
2025-09-30 $4,986,297 35,520
2025-06-30 $6,787,260 54,000
2025-03-31 $9,833,999 88,915
2024-12-31 $9,171,298 67,189
2024-09-30 $60,394,636 524,168
2024-06-30 $99,272,047 721,087
2024-03-31 $98,309,100 712,798
2023-12-31 $99,197,492 752,865
2023-09-30 $77,892,075 692,374
2023-06-30 $41,063,312 435,454
2023-03-31 $43,659,829 431,336
2022-12-31 $7,656,940 64,107
2022-09-30 $1,440,951 13,567
2020-12-31 $604,621 6,308
2020-09-30 $3,027,212 31,481
2020-06-30 $3,359,148 27,534
2020-03-31 $13,020,928 150,444